Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neuropathological Staging of Brain Pathology in Sporadic Parkinson’s disease: Separating the Wheat from the Chaff
Heiko Braak, Kelly Del Tredici
Journal of Parkinson s Disease (2017) Vol. 7, Iss. s1, pp. S71-S85
Open Access | Times Cited: 341

Showing 1-25 of 341 citing articles:

Selective neuronal vulnerability in Parkinson disease
D. James Surmeier, José Á. Obeso, Glenda M. Halliday
Nature reviews. Neuroscience (2017) Vol. 18, Iss. 2, pp. 101-113
Open Access | Times Cited: 896
Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology
David K. Simon, Caroline M. Tanner, Patrik Brundin
Clinics in Geriatric Medicine (2019) Vol. 36, Iss. 1, pp. 1-12
Open Access | Times Cited: 799
Animal models of neurodegenerative diseases
Ted M. Dawson, Todd E. Golde, Clotilde Lagier‐Tourenne
Nature Neuroscience (2018) Vol. 21, Iss. 10, pp. 1370-1379
Open Access | Times Cited: 486
Selective vulnerability in neurodegenerative diseases
Hongjun Fu, John Hardy, Karen Duff
Nature Neuroscience (2018) Vol. 21, Iss. 10, pp. 1350-1358
Open Access | Times Cited: 479
The genetics of Parkinson disease
Hao Deng, Peng Wang, Joseph Jankovic
Ageing Research Reviews (2017) Vol. 42, pp. 72-85
Closed Access | Times Cited: 466
On Cell Loss and Selective Vulnerability of Neuronal Populations in Parkinson's Disease
Nicolas Giguère, Samuel Burke Nanni, Louis‐Éric Trudeau
Frontiers in Neurology (2018) Vol. 9
Open Access | Times Cited: 349
Amyloid-β and tau complexity — towards improved biomarkers and targeted therapies
Juan Carlos Polanco, Chuanzhou Li, Liviu‐Gabriel Bodea, et al.
Nature Reviews Neurology (2017) Vol. 14, Iss. 1, pp. 22-39
Closed Access | Times Cited: 348
Determinants of dopaminergic neuron loss in Parkinson's disease
D. James Surmeier
FEBS Journal (2018) Vol. 285, Iss. 19, pp. 3657-3668
Open Access | Times Cited: 338
Long Road to Ruin: Noradrenergic Dysfunction in Neurodegenerative Disease
David Weinshenker
Trends in Neurosciences (2018) Vol. 41, Iss. 4, pp. 211-223
Open Access | Times Cited: 266
Dementia with Lewy bodies and Parkinson’s disease-dementia: current concepts and controversies
K. A. Jellinger
Journal of Neural Transmission (2017) Vol. 125, Iss. 4, pp. 615-650
Closed Access | Times Cited: 231
Enhancing glycolysis attenuates Parkinson’s disease progression in models and clinical databases
Rong Cai, Y Zhang, Jacob E. Simmering, et al.
Journal of Clinical Investigation (2019) Vol. 129, Iss. 10, pp. 4539-4549
Open Access | Times Cited: 224
Therapeutic approaches to target alpha-synuclein pathology
Patrik Brundin, Kuldip D. Dave, Jeffrey H. Kordower
Experimental Neurology (2017) Vol. 298, pp. 225-235
Open Access | Times Cited: 218
Skin α-Synuclein Aggregation Seeding Activity as a Novel Biomarker for Parkinson Disease
Zerui Wang, Katelyn Becker, Vincenzo Donadio, et al.
JAMA Neurology (2020) Vol. 78, Iss. 1, pp. 30-30
Open Access | Times Cited: 188
Recent progress of drug nanoformulations targeting to brain
Abdur Rauf Khan, Xiaoye Yang, Manfei Fu, et al.
Journal of Controlled Release (2018) Vol. 291, pp. 37-64
Closed Access | Times Cited: 182
Interplay of gut microbiota and oxidative stress: Perspective on neurodegeneration and neuroprotection
Shruti Shandilya, Sandeep Kumar, Niraj Kumar Jha, et al.
Journal of Advanced Research (2021) Vol. 38, pp. 223-244
Open Access | Times Cited: 182
Oxidative Stress and the Microbiota‐Gut‐Brain Axis
Laura Dumitrescu, Iulia Popescu-Olaru, Liviu Cozma, et al.
Oxidative Medicine and Cellular Longevity (2018) Vol. 2018, Iss. 1
Open Access | Times Cited: 179
CD8 T cell nigral infiltration precedes synucleinopathy in early stages of Parkinson’s disease
Jordi Galiano-Landeira, Albert Torra, Miquel Vila, et al.
Brain (2020) Vol. 143, Iss. 12, pp. 3717-3733
Open Access | Times Cited: 176
Motor and non-motor circuit disturbances in early Parkinson disease: which happens first?
Javier Blesa, Guglielmo Foffani, Benjamin Dehay, et al.
Nature reviews. Neuroscience (2021) Vol. 23, Iss. 2, pp. 115-128
Closed Access | Times Cited: 157
Increased DJ-1 and α-Synuclein in Plasma Neural-Derived Exosomes as Potential Markers for Parkinson’s Disease
Zhenhua Zhao, Zhiting Chen, Ruiling Zhou, et al.
Frontiers in Aging Neuroscience (2019) Vol. 10
Open Access | Times Cited: 146
GBA Variants and Parkinson Disease: Mechanisms and Treatments
Laura Smith, Anthony H.V. Schapira
Cells (2022) Vol. 11, Iss. 8, pp. 1261-1261
Open Access | Times Cited: 135
Evaluation of fecal microbiota transplantation in Parkinson's disease patients with constipation
Xiaoyi Kuai, Xiaohan Yao, Lijuan Xu, et al.
Microbial Cell Factories (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 123
α-Synuclein Seed Amplification Assays for Diagnosing Synucleinopathies
G. Bellomo, Chiara Maria Giulia De Luca, Federico Paolini Paoletti, et al.
Neurology (2022) Vol. 99, Iss. 5, pp. 195-205
Closed Access | Times Cited: 91
Multimodal brain and retinal imaging of dopaminergic degeneration in Parkinson disease
Jee‐Young Lee, Antonio Martín‐Bastida, Ane Murueta‐Goyena, et al.
Nature Reviews Neurology (2022) Vol. 18, Iss. 4, pp. 203-220
Closed Access | Times Cited: 81
Neuropathology of incidental Lewy body & prodromal Parkinson’s disease
Thomas Koeglsperger, S Rumpf, Patricia Schließer, et al.
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 60
Proposal for a Biologic Staging System of Parkinson’s Disease
Lana M. Chahine, Kalpana Merchant, Andrew Siderowf, et al.
Journal of Parkinson s Disease (2023) Vol. 13, Iss. 3, pp. 297-309
Open Access | Times Cited: 57
Page 1 - Next Page

Scroll to top